Press Releases Archives - Page 84 of 103 - Lupin

BSE 2328.10 NSE 2324.50

indian flag icon

India

USA

great-britain flag icon

UK

south-africa flag icon

South Africa

australia flag icon

Australia

philippines flag icon

Philippines

germany flag icon

Germany

netherlands flag icon

Netherlands

mexico flag icon

Mexico

brazil flag icon

Brazil

canada flag icon

Canada

Switzerland flag icon

Switzerland

BSE 2328.10 NSE 2324.50

Lupin receives FDA approval for SUPRAX® (Cefixime) Capsules, 400 mg NDA Approval to add to growing SUPRAX® Franchise ®

Lupin Launches Generic Combivir® Tablets

Lupin Sales and Operating Profit up 22%

Lupin To Set Up New Formulations Manufacturing Facility In MIHAN

Lupin Resumes Sales of Generic Fortamet®

Lupin launchesGeneric SEROQUEL® Tablets Receives final FDA Approval for its Generic SEROQUEL® Tablets

Lupin launchesGeneric Geodon® Capsules Receives final FDA Approval for its Generic Geodon® Capsules

LUPIN announces settlement with SANTARUS and DEPOMED for GLUMETZA Patent Litigation

February 22, 2012

Lupin receives Tentative Approval for Generic Glumetza® Extended-Release Tablets

January 30, 2012

Strong Growth, Robust Operating Performance

January 24, 2012

1 2 … 83 84 85 … 102 103

Search

Hit enter to search or ESC to close